Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions

Human Genetics

Volumn 133, Issue 9, 2014, Pages 1187-1197

  Li, Xuelin ^a   Price, Matthew A ^b,c   He, Dongning ^d   Kamali, Anatoli ^e   Karita, Etienne ^f   Lakhi, Shabir ^g   Sanders, Eduard J ^h,i   Anzala, Omu ^j   Amornkul, Pauli N ^b,c   Allen, Susan ^f,g,k   Hunter, Eric ^l   Kaslow, Richard A ^b,n   Gilmour, Jill ^m   Tang, Jianming ^a,d  

^a University of Alabama at Birmingham   (United States)

^b INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e MRC/UVRI Uganda Virus Research Unit on AIDS   (Uganda)

^f Projet San Francisco   (Rwanda)

^g Zambia Emory HIV Research Project   (Zambia)

^h KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j Kenya AIDS Vaccine Initiative (KAVI)   (Kenya)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l EMORY UNIVERSITY   (United States)

^m CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

ⁿ DEPARTMENT OF VETERANS AFFAIRS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA A3 ANTIGEN; HLA ANTIGEN; HLA B18 ANTIGEN; HLA B45 ANTIGEN; HLA B53 ANTIGEN; HLA B57 ANTIGEN; HLA C ANTIGEN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADULT; ALLELE; ARTICLE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HERITABILITY; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE GENETICS; SEX DIFFERENCE; VIRAL GENETICS; VIRUS LOAD;

ADULT; AFRICA, EASTERN; AFRICA, WESTERN; ALLELES; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC VARIATION; HAPLOTYPES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; QUANTITATIVE TRAIT, HERITABLE; SEX FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84907424572     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-014-1465-x     Document Type: Article

References (75)

1. Almeida CA, Bronke C, Roberts SG, McKinnon E, Keane NM, Chopra A, Kadie C, Carlson J, Haas DW, Riddler SA, Haubrich R, Heckerman D, Mallal S, John M (2011) Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes. J Immunol 187:2502–2513. doi:10.4049/jimmunol.1100691
2. Amornkul PN, Karita E, Kamali A, Rida WN, Sanders EJ, Lakhi S, Price MA, Kilembe W, Cormier E, Anzala O, Latka MH, Bekker LG, Allen SA, Gilmour J, Fast PE, Partnership IAHP (2013) Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa. AIDS 27:2775–2786. doi:10.1097/QAD.0000000000000012
3. Apps R, Qi Y, Carlson JM, Chen H, Gao X, Thomas R, Yuki Y, Del Prete GQ, Goulder P, Brumme ZL, Brumme CJ, John M, Mallal S, Nelson G, Bosch R, Heckerman D, Stein JL, Soderberg KA, Moody MA, Denny TN, Zeng X, Fang J, Moffett A, Lifson JD, Goedert JJ, Buchbinder S, Kirk GD, Fellay J, McLaren P, Deeks SG, Pereyra F, Walker B, Michael NL, Weintrob A, Wolinsky S, Liao W, Carrington M (2013) Influence of HLA-C expression level on HIV control. Science 340:87–91. doi:10.1126/science.1232685340/6128/87
4. Balamurugan A, Ng HL, Yang OO (2010) Rapid T cell receptor delineation reveals clonal expansion limitation of the magnitude of the HIV-1-specific CD8+ T cell response. J Immunol 185:5935–5942. doi:10.4049/jimmunol.1002236
5. Bansal A, Yue L, Conway J, Yusim K, Tang J, Kappes J, Kaslow RA, Wilson CM, Goepfert PA (2007) Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents. AIDS 21:2387–2397
6. Berger CT, Carlson JM, Brumme CJ, Hartman KL, Brumme ZL, Henry LM, Rosato PC, Piechocka-Trocha A, Brockman MA, Harrigan PR, Heckerman D, Kaufmann DE, Brander C (2010) Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences. J Exp Med 207:61–75. doi:10.1084/jem.20091808
7. Brookfield JF (2013) Quantitative genetics: heritability is not always missing. Curr Biol 23:R276–R278. doi:10.1016/j.cub.2013.02.040
8. Brumme ZL, Brumme CJ, Carlson J, Streeck H, John M, Eichbaum Q, Block BL, Baker B, Kadie C, Markowitz M, Jessen H, Kelleher AD, Rosenberg E, Kaldor J, Yuki Y, Carrington M, Allen TM, Mallal S, Altfeld M, Heckerman D, Walker BD (2008) Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 82:9216–9227. doi:10.1128/JVI.01041-08
9. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernandez-Vina MA (2001) Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 62:1009–1030
10. Cardoso CS, de Sousa M (2003) HFE, the MHC and hemochromatosis: paradigm for an extended function for MHC class I. Tissue Antigens 61:263–275
11. Chen H, Piechocka-Trocha A, Miura T, Brockman MA, Julg BD, Baker BM, Rothchild AC, Block BL, Schneidewind A, Koibuchi T, Pereyra F, Allen TM, Walker BD (2009) Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes. J Virol 83:3138–3149. doi:10.1128/JVI.02073-08
12. Crawford H, Lumm W, Leslie A, Schaefer M, Boeras D, Prado JG, Tang J, Farmer P, Ndung’u T, Lakhi S, Gilmour J, Goepfert P, Walker BD, Kaslow R, Mulenga J, Allen S, Goulder PJ, Hunter E (2009) Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J Exp Med 206:909–921
13. Davis CF, Dorak MT (2010) An extensive analysis of the hereditary hemochromatosis gene HFE and neighboring histone genes: associations with childhood leukemia. Ann Hematol 89:375–384. doi:10.1007/s00277-009-0839-y
14. de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, Ke X, Monsuur AJ, Whittaker P, Delgado M, Morrison J, Richardson A, Walsh EC, Gao X, Galver L, Hart J, Hafler DA, Pericak-Vance M, Todd JA, Daly MJ, Trowsdale J, Wijmenga C, Vyse TJ, Beck S, Murray SS, Carrington M, Gregory S, Deloukas P, Rioux JD (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 38:1166–1172. doi:10.1038/ng1885
15. Dinges WL, Richardt J, Friedrich D, Jalbert E, Liu Y, Stevens CE, Maenza J, Collier AC, Geraghty DE, Smith J, Moodie Z, Mullins JI, McElrath MJ, Horton H (2010) Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype. J Virol 84:4461–4468. doi:10.1128/JVI.02438-09
16. Dorak MT, Lawson T, Machulla HK, Darke C, Mills KI, Burnett AK (1999) Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia. Blood 94:694–700
17. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH (2010) Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11:446–450. doi:10.1038/nrg2809
18. ENCODE Project Consortium, Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489:57–74. doi:10.1038/nature11247
19. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, Dilthey A, Ellis P, Langford C, Vannberg FO, Knight JC (2012) Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet 44:502–510. doi:10.1038/ng.2205
20. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, Cozzi-Lepri A, De Luca A, Easterbrook P, Francioli P, Mallal S, Martinez-Picado J, Miro JM, Obel N, Smith JP, Wyniger J, Descombes P, Antonarakis SE, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Goldstein DB (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317:944–947
21. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP, Castagna A, Cozzi-Lepri A, De Luca A, Easterbrook P, Gunthard HF, Mallal S, Mussini C, Dalmau J, Martinez-Picado J, Miro JM, Obel N, Wolinsky SM, Martinson JJ, Detels R, Margolick JB, Jacobson LP, Descombes P, Antonarakis SE, Beckmann JS, O’Brien SJ, Letvin NL, McMichael AJ, Haynes BF, Carrington M, Feng S, Telenti A, Goldstein DB (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5:e1000791
22. Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H, Mulenga J, Kasolo F, Vermund SH, Aldrovandi GM (2001) Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retrovir 17:901–910. doi:10.1089/088922201750290023
23. Gianola D, Hospital F, Verrier E (2013) Contribution of an additive locus to genetic variance when inheritance is multi-factorial with implications on interpretation of GWAS. Theor Appl Genet 126:1457–1472. doi:10.1007/s00122-013-2064-2
24. Goulder PJ, Walker BD (2012) HIV and HLA class I: an evolving relationship. Immunity 37:426–440. doi:10.1016/j.immuni.2012.09.005
25. Goulder PJ, Sewell AK, Lalloo DG, Price DA, Whelan JA, Evans J, Taylor GP, Luzzi G, Giangrande P, Phillips RE, McMichael AJ (1997) Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J Exp Med 185:1423–1433
26. Hanson EH, Imperatore G, Burke W (2001) HFE gene and hereditary hemochromatosis: a HuGE review. Am J Epidemiol 154:193–206
27. Heath SL, Sabbaj S, Bansal A, Kilby JM, Goepfert PA (2011) CD8 T-cell proliferative capacity is compromised in primary HIV-1 infection. J Acquir Immune Defic Syndr 56:213–221. doi:10.1097/QAI.0b013e3181ff2aba
28. Hendel H, Caillat-Zucman S, Lebuanec H, Carrington M, O’Brien S, Andrieu JM, Schachter F, Zagury D, Rappaport J, Winkler C, Nelson GW, Zagury JF (1999) New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 162:6942–6946
29. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, O’Brien SJ, Rinaldo C, Detels R, Blattner W, Phair J, Erlich H, Mann DL (1996) Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2:405–411
30. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M, Gatanaga H, Fujiwara M, Hachiya A, Koizumi H, Kuse N, Oka S, Duda A, Prendergast A, Crawford H, Leslie A, Brumme Z, Brumme C, Allen T, Brander C, Kaslow R, Tang J, Hunter E, Allen S, Mulenga J, Branch S, Roach T, John M, Mallal S, Ogwu A, Shapiro R, Prado JG, Fidler S, Weber J, Pybus OG, Klenerman P, Ndung’u T, Phillips R, Heckerman D, Harrigan PR, Walker BD, Takiguchi M, Goulder P (2009) Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458:641–645
31. Keller MF, Saad M, Bras J, Bettella F, Nicolaou N, Simon-Sanchez J, Mittag F, Buchel F, Sharma M, Gibbs JR, Schulte C, Moskvina V, Durr A, Holmans P, Kilarski LL, Guerreiro R, Hernandez DG, Brice A, Ylikotila P, Stefansson H, Majamaa K, Morris HR, Williams N, Gasser T, Heutink P, Wood NW, Hardy J, Martinez M, Singleton AB, Nalls MA, International Parkinson’s Disease Genomics C, Wellcome Trust Case Control C (2012) Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease. Hum Mol Genet 21:4996–5009. doi:10.1093/hmg/dds335
32. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, Zimbwa P, Moore S, Allen T, Brander C, Addo MM, Altfeld M, James I, Mallal S, Bunce M, Barber LD, Szinger J, Day C, Klenerman P, Mullins J, Korber B, Coovadia HM, Walker BD, Goulder PJ (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432:769–775. doi:10.1038/nature03113
33. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, Reddy S, de Pierres C, Mncube Z, Mkhwanazi N, Bishop K, van der Stok M, Nair K, Khan N, Crawford H, Payne R, Leslie A, Prado J, Prendergast A, Frater J, McCarthy N, Brander C, Learn GH, Nickle D, Rousseau C, Coovadia H, Mullins JI, Heckerman D, Walker BD, Goulder P (2007) CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13:46–53. doi:10.1038/nm1520
34. + double positive thymocytes. J Exp Med 190:217–228
35. Koehler RN, Walsh AM, Saathoff E, Tovanabutra S, Arroyo MA, Currier JR, Maboko L, Hoelscher M, Robb ML, Michael NL, McCutchan FE, Kim JH, Kijak GH (2010) Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania. J Infect Dis 202:1562–1566. doi:10.1086/656913
36. Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, McNicholl JM, Gardner LI, Wilson CM, Klein RS, Rompalo A, Mayer K, Sobel J, Kaslow RA (2011) The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans. Hum Immunol 72:312–318
37. Lee SH, Wray NR, Goddard ME, Visscher PM (2011) Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 88:294–305. doi:10.1016/j.ajhg.2011.02.002
38. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, St John A, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, Goulder PJ (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10:282–289. doi:10.1038/nm992nm992
39. Leslie A, Matthews PC, Listgarten J, Carlson JM, Kadie C, Ndung’u T, Brander C, Coovadia H, Walker BD, Heckerman D, Goulder PJ (2010) Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 84:9879–9888. doi:10.1128/JVI.00320-10
40. Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, Margolick JB, Phair JP, Mellors JW (2000) Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis 181:872–880. doi:10.1086/315339
41. Mahachie John JM, Van Lishout F, Van Steen K (2011) Model-based multifactor dimensionality reduction to detect epistasis for quantitative traits in the presence of error-free and noisy data. Eur J Hum Genet 19:696–703. doi:10.1038/ejhg.2011.17
42. Mann DL, Garner RP, Dayhoff DE, Cao K, Fernandez-Vina MA, Davis C, Aronson N, Ruiz N, Birx DL, Michael NL (1998) Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans. J Infect Dis 178:1799–1802
43. McKinnon LR, Ball TB, Wachihi C, McLaren PJ, Waruk JL, Mao X, Ramdahin S, Anzala AO, Kamene J, Luo M, Fowke KR, Plummer FA (2007) Epitope cross-reactivity frequently differs between central and effector memory HIV-specific CD8+ T cells. J Immunol 178:3750–3756
44. McLaren PJ, Ripke S, Pelak K, Weintrob AC, Patsopoulos NA, Jia X, Erlich RL, Lennon NJ, Kadie CM, Heckerman D, Gupta N, Haas DW, Deeks SG, Pereyra F, Walker BD, de Bakker PI (2012) Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans. Hum Mol Genet 21:4334–4347. doi:10.1093/hmg/dds226
45. Mellors JW, Kingsley LA, Rinaldo CR Jr, Todd JA, Hoo BS, Kokka RP, Gupta P (1995) Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Internal Med 122:573–579
46. Modjarrad K, Chamot E, Vermund SH (2008) Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 22:2179–2185. doi:10.1097/QAD.0b013e328312c756
47. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA (2002) Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439–1443. doi:10.1126/science.1069660296/5572/1439
48. Morrison BA, Ucisik-Akkaya E, Flores H, Alaez C, Gorodezky C, Dorak MT (2010) Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk. Autoimmunity 43:690–697. doi:10.3109/08916930903567492
49. Ngongo PB, Priddy F, Park H, Becker J, Bender B, Fast P, Anzala O, Mutua G, Ruzagira E, Kamali A, Karita E, Mugo P, Chomba E, Bekker LG, Roux S, Nanvubya A, Mebrahtu T (2012) Developing standards of care for HIV prevention research in developing countries—a case study of 10 research centers in Eastern and Southern Africa. AIDS Care 24:1277–1289. doi:10.1080/09540121.2012.656572
50. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ (2010) Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 6:e1000888. doi:10.1371/journal.pgen.1000888
51. Novitsky V, Wang R, Margolin L, Baca J, Moyo S, Musonda R, Essex M (2010) Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection. Virology 403:37–46. doi:10.1016/j.virol.2010.04.001
52. Peretz Y, Marra O, Thomas R, Legault D, Cote P, Boulassel MR, Rouleau D, Routy JP, Sekaly RP, Tsoukas CM, Tremblay C, Bernard NF (2011) Relative contribution of HIV-specific functional lymphocyte subsets restricted by protective and non-protective HLA alleles. Viral Immunol 24:189–198. doi:10.1089/vim.2010.0117
53. Prentice HA, Tang J (2012) HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues. Viruses 4:2080–2096. doi:10.3390/v4102080v4102080
54. Prentice HA, Price MA, Porter TR, Cormier E, Mugavero MJ, Kamali A, Karita E, Lakhi S, Sanders EJ, Anzala O, Amornkul PN, Allen S, Hunter E, Kaslow RA, Gilmour J, Tang J, IAVI Africa HIV Prevention Partnership (2014a) Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates. Virology 449:254–262. doi:10.1016/j.virol.2013.11.024
55. Prentice HA, Pajewski NM, He D, Zhang K, Brown EE, Kilembe W, Allen S, Hunter E, Kaslow RA, Tang J (2014b) Host genetics and immune control of HIV-1 infection: fine mapping for the extended human MHC region in an African cohort. Genes Immun. doi:10.1038/gene.2014.16
56. Price MA, Wallis CL, Lakhi S, Karita E, Kamali A, Anzala O, Sanders EJ, Bekker LG, Twesigye R, Hunter E, Kaleebu P, Kayitenkore K, Allen S, Ruzagira E, Mwangome M, Mutua G, Amornkul PN, Stevens G, Pond SL, Schaefer M, Papathanasopoulos MA, Stevens W, Gilmour J (2011) Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa. AIDS Res Hum Retrovir 27:5–12. doi:10.1089/aid.2010.0030
57. Prince JL, Claiborne DT, Carlson JM, Schaefer M, Yu T, Lahki S, Prentice HA, Yue L, Vishwanathan SA, Kilembe W, Goepfert P, Price MA, Gilmour J, Mulenga J, Farmer P, Derdeyn CA, Tang J, Heckerman D, Kaslow RA, Allen SA, Hunter E (2012) Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis. PLoS Pathog 8:e1003041. doi:10.1371/journal.ppat.1003041
58. Putter C, Pechlivanis S, Nothen MM, Jockel KH, Wichmann HE, Scherag A (2011) Missing heritability in the tails of quantitative traits? A simulation study on the impact of slightly altered true genetic models. Hum Hered 72:173–181. doi:10.1159/000332824
59. Queitsch C, Carlson KD, Girirajan S (2012) Lessons from model organisms: phenotypic robustness and missing heritability in complex disease. PLoS Genet 8:e1003041. doi:10.1371/journal.pgen.1003041
60. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 342:921–929
61. Rajapaksa US, Li D, Peng YC, McMichael AJ, Dong T, Xu XN (2012) HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation. Proc Natl Acad Sci USA 109:13353–13358. doi:10.1073/pnas.12041991091204199109
62. Rolland M, Carlson JM, Manocheewa S, Swain JV, Lanxon-Cookson E, Deng W, Rousseau CM, Raugi DN, Learn GH, Maust BS, Coovadia H, Ndung’u T, Goulder PJ, Walker BD, Brander C, Heckerman DE, Mullins JI (2010) Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics. PLoS ONE 5:e12463. doi:10.1371/journal.pone.0012463
63. Rosenbloom KR, Dreszer TR, Pheasant M, Barber GP, Meyer LR, Pohl A, Raney BJ, Wang T, Hinrichs AS, Zweig AS, Fujita PA, Learned K, Rhead B, Smith KE, Kuhn RM, Karolchik D, Haussler D, Kent WJ (2010) ENCODE whole-genome data in the UCSC Genome Browser. Nucleic Acids Res 38:D620–D625. doi:10.1093/nar/gkp961
64. Saag MS, Holodniy M, Kuritzkes DR, O’Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA (1996) HIV viral load markers in clinical practice. Nat Med 2:625–629
65. Schneidewind A, Tang Y, Brockman MA, Ryland EG, Dunkley-Thompson J, Steel-Duncan JC, St John MA, Conrad JA, Kalams SA, Noel F, Allen TM, Christie CD, Feeney ME (2009) Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant. J Virol 83:8616–8627. doi:10.1128/JVI.00730-09
66. Song W, Ruder AM, Hu L, Li Y, Ni R, Shao W, Kaslow RA, Butler M, Tang J (2009) Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs. PLoS ONE 4:e7157. doi:10.1371/journal.pone.0007157
67. Tang J, Tang S, Lobashevsky E, Myracle AD, Fideli U, Aldrovandi G, Allen S, Musonda R, Kaslow RA (2002) Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J Virol 76:8276–8284
68. Tang J, Malhotra R, Song W, Brill I, Hu L, Farmer PK, Mulenga J, Allen S, Hunter E, Kaslow RA (2010) Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships. PLoS ONE 5:e9629
69. Tang J, Cormier E, Gilmour J, Price MA, Prentice HA, Song W, Kamali A, Karita E, Lakhi S, Sanders EJ, Anzala O, Amornkul PN, Allen S, Hunter E, Kaslow RA (2011) Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes. J Virol 85:8894–8902
70. Turnbull EL, Wong M, Wang S, Wei X, Jones NA, Conrod KE, Aldam D, Turner J, Pellegrino P, Keele BF, Williams I, Shaw GM, Borrow P (2009) Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection. J Immunol 182:7131–7145. doi:10.4049/jimmunol.0803658
71. Vandiedonck C, Knight JC (2009) The human major histocompatibility complex as a paradigm in genomics research. Brief Funct Genomic Proteomic 8:379–394. doi:10.1093/bfgp/elp010
72. Wang YE, Li B, Carlson JM, Streeck H, Gladden AD, Goodman R, Schneidewind A, Power KA, Toth I, Frahm N, Alter G, Brander C, Carrington M, Walker BD, Altfeld M, Heckerman D, Allen TM (2009) Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. J Virol 83:1845–1855. doi:10.1128/JVI.01061-08
73. Ward LD, Kellis M (2012) HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 40:D930–D934. doi:10.1093/nar/gkr917
74. Yang OO, Daar ES, Jamieson BD, Balamurugan A, Smith DM, Pitt JA, Petropoulos CJ, Richman DD, Little SJ, Brown AJ (2005) Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol 79:860–868. doi:10.1128/JVI.79.2.860-868.2005
75. Yue L, Prentice HA, Farmer P, Song W, He D, Lakhi S, Goepfert P, Gilmour J, Allen S, Tang J, Kaslow RA, Hunter E (2013) Cumulative impact of host and viral factors on HIV-1 viral load control during early infection. J Virol 87:708–715. doi:10.1128/JVI.02118-12